Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy
Clinical trial NCT00000807 · COMPLETED
Trial details
- NCT number
- NCT00000807
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.